What is Avalon Globocare Corp's earnings per share (EPS)?

Avalon Globocare Corp (ALBT) reported diluted earnings per share of $-5.64 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Avalon Globocare Corp Financials

ALBT

Source SEC Filings (10-K/10-Q) Data as of Mar 31, 2026 Currency USD FYE December

This page shows Avalon Globocare Corp (ALBT) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 10 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI ALBT FY2025 2026-05-11

Outside capital, not internally generated cash, still appears to fund the business as near-term liquidity tightens.

Operating cash outflow improved from -$6.5M two years earlier to -$4.6M in the latest year. But cash still ended at only $109K, and financing inflow was just $1.4M; that cash burn versus cash on hand mismatch says external funding no longer covered a full year of operations even though the burn rate moderated.

Reported assets are not the same as usable liquidity. Goodwill reached $12.8M in the latest year, and current assets were only $1.5M. Against $14.1M of current liabilities, that asset mix leaves little short-term flexibility despite positive equity on paper.

The loss figure became less informative about cash use in the latest year. Net loss widened to -$18.3M, but operating cash outflow was -$4.6M; the gap points to heavier noncash charges and financing costs rather than a matching deterioration in day-to-day cash spending. Interest expense rose sharply to $1.5M after $42K a year earlier, so more of the reported loss now comes from financing structure instead of the core operating bill.

Financial Health Signals

Financial health score pending refresh

We are recalculating Avalon Globocare Corp's peer-relative financial health score against the latest fiscal year. It will appear here once the refresh completes. The signals and metrics below are current.

Piotroski F-Score Partial

1/6

Avalon Globocare Corp passes 1 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution).

Earnings Quality Low Quality

0.25x

For every $1 of reported earnings, Avalon Globocare Corp generates $0.25 in operating cash flow (-$4.6M OCF vs -$18.3M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk

-5.2x

Avalon Globocare Corp earns $-5.2 in operating income for every $1 of interest expense (-$7.6M vs $1.5M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

N/A

EBITDA

-$5.3M

YoY-27.9%

Avalon Globocare Corp's EBITDA was -$5.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 27.9% from the prior year.

Net Income

-$18.3M

YoY-131.1%

Avalon Globocare Corp reported -$18.3M in net income in fiscal year 2025. This represents a decrease of 131.1% from the prior year.

EPS (Diluted)

$-5.64

Avalon Globocare Corp earned $-5.64 per diluted share (EPS) in fiscal year 2025.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$109K

YoY-95.9%

5Y CAGR-31.6%

Avalon Globocare Corp held $109K in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

Avalon Globocare Corp had 5M shares outstanding in fiscal year 2025.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

N/A

Return on Equity

-197.8%

YoY-86.6pp

5Y CAGR+110.1pp

Avalon Globocare Corp's ROE was -197.8% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 86.6 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

N/A

ALBT Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	N/A	$1.3M-1.3%	$1.4M-62.2%	$3.6M+157.1%	$1.4M+1.0%	$1.4M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	$273K-34.2%	$415K+6.2%	$390K
R&D Expenses	N/A	$0-100.0%	$110K-85.0%	$731K-28.7%	$1.0M+16.0%	$884K
SG&A Expenses	$1.1M-15.8%	$1.3M-26.0%	$1.8M-5.1%	$1.9M-8.8%	$2.0M-50.9%	$4.2M
Operating Income	-$7.6M-56.8%	-$4.8M+69.3%	-$15.8M-79.2%	-$8.8M+0.5%	-$8.8M+29.1%	-$12.5M
Interest Expense	$1.5M+3332.0%	$42K+25.9%	$34K-80.8%	$176K	N/A	N/A
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	-$18.3M-131.1%	-$7.9M+52.7%	-$16.7M-40.0%	-$11.9M-31.2%	-$9.1M+28.3%	-$12.7M
EPS (Diluted)	$-5.64	$-8.44+64.5%	$-23.80	$-1.28	$-1.07	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Revenue	N/A	N/A	$350K-0.1%	$350K+0.2%	$350K+147.5%	$141K-59.0%	$345K+5.3%	$328K
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$223K	N/A	$230K-28.9%	$324K+4.9%	$309K+21.3%	$255K-25.8%	$343K-3.9%	$357K
Operating Income	-$2.7M	N/A	-$76K+98.0%	-$3.9M-117.8%	-$1.8M-45.9%	-$1.2M+3.6%	-$1.3M+15.6%	-$1.5M
Interest Expense	$23K	N/A	$267K-74.7%	$1.1M+88.9%	$560K+142.3%	-$1.3M-341.8%	$547K-32.3%	$808K
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	-$4.5M	N/A	-$254K+98.1%	-$13.5M-442.2%	-$2.5M+8.9%	-$2.7M-62.3%	-$1.7M+21.2%	-$2.1M
EPS (Diluted)	$-0.50	N/A	$-0.06+99.0%	$-6.22-335.0%	$-1.43	N/A	$-1.82	$-2.85

ALBT Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$23.4M+11.5%	$21.0M+2.0%	$20.6M+4.2%	$19.8M+92.8%	$10.2M-1.2%	$10.4M
Current Assets	$1.5M-53.8%	$3.2M+280.4%	$851K-64.2%	$2.4M+79.4%	$1.3M+2.9%	$1.3M
Cash & Equivalents	$109K-95.9%	$2.7M+831.4%	$285K-85.7%	$2.0M+146.5%	$808K+11.1%	$727K
Inventory	$75K-18.9%	$92K	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	$74K	N/A	N/A
Goodwill	$12.8M	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$14.2M+2.1%	$13.9M+5.1%	$13.2M+53.8%	$8.6M+20.0%	$7.2M+14.5%	$6.2M
Current Liabilities	$14.1M+1.9%	$13.9M+105.3%	$6.8M+88.9%	$3.6M-18.7%	$4.4M+69.8%	$2.6M
Long-Term Debt	N/A	N/A	N/A	N/A	$3.0M	N/A
Total Equity	$9.2M+30.0%	$7.1M-3.6%	$7.4M-34.0%	$11.2M+261.8%	$3.1M-25.1%	$4.1M
Retained Earnings	-$105.9M-20.8%	-$87.7M-9.9%	-$79.8M-26.5%	-$63.1M-23.3%	-$51.1M-21.6%	-$42.0M

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Total Assets	$16.2M-30.6%	$23.4M+156.3%	$9.1M+14.3%	$8.0M-24.7%	$10.6M-49.4%	$21.0M+7.3%	$19.6M+0.2%	$19.5M
Current Assets	$1.7M+11.6%	$1.5M-28.4%	$2.1M+123.9%	$933K-66.6%	$2.8M-13.7%	$3.2M+131.7%	$1.4M+95.9%	$713K
Cash & Equivalents	$776K+611.3%	$109K-67.3%	$334K+65.7%	$202K-85.3%	$1.4M-48.5%	$2.7M+159.5%	$1.0M+410.6%	$201K
Inventory	$72K-4.0%	$75K-6.5%	$80K-7.4%	$86K-4.1%	$90K-2.3%	$92K	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	$12.8M0.0%	$12.8M	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$4.5M-68.1%	$14.2M+4.0%	$13.6M-9.8%	$15.1M+4.1%	$14.5M+4.5%	$13.9M-1.9%	$14.1M-6.3%	$15.1M
Current Liabilities	$4.4M-68.6%	$14.1M+4.0%	$13.6M-9.7%	$15.1M+4.3%	$14.4M+4.1%	$13.9M+12.6%	$12.3M+43.5%	$8.6M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$11.7M+27.0%	$9.2M+305.4%	-$4.5M+36.8%	-$7.1M-82.8%	-$3.9M-154.8%	$7.1M+31.5%	$5.4M+22.3%	$4.4M
Retained Earnings	-$110.4M-4.2%	-$105.9M-2.0%	-$103.9M-0.2%	-$103.6M-14.9%	-$90.2M-2.8%	-$87.7M-3.2%	-$84.9M-2.0%	-$83.3M

ALBT Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	-$4.6M+7.8%	-$5.0M+23.6%	-$6.5M+7.6%	-$7.0M-40.1%	-$5.0M+33.4%	-$7.5M
Capital Expenditures	N/A	N/A	$22K+1167.0%	$2K-90.0%	$18K	N/A
Free Cash Flow	N/A	N/A	-$6.5M+7.3%	-$7.0M-39.6%	-$5.0M	N/A
Investing Cash Flow	N/A	-$100K-351.3%	-$22K+99.8%	-$9.1M-13187.5%	-$68K+59.7%	-$169K
Financing Cash Flow	$1.4M-81.7%	$7.6M+58.3%	$4.8M-72.0%	$17.3M+233.9%	$5.2M-32.5%	$7.7M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	-$2.9M-1389.3%	-$192K+85.9%	-$1.4M-11.0%	-$1.2M+32.0%	-$1.8M-67.1%	-$1.1M+43.1%	-$1.9M-75.0%	-$1.1M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	$281K	N/A	$658K	$0-100.0%	$95K	$0	$0	N/A
Financing Cash Flow	$3.4M+1093.5%	$288K-65.5%	$835K+1348.5%	$58K-73.8%	$220K-92.4%	$2.9M+7.2%	$2.7M+153.0%	$1.1M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

ALBT Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	7.6%-22.2pp	29.8%+1.5pp	28.3%
Operating Margin	N/A	-363.1%+802.6pp	-1165.6%-919.8pp	-245.9%+389.2pp	-635.1%+268.9pp	-903.9%
Net Margin	N/A	-592.7%+643.5pp	-1236.2%-902.6pp	-333.6%+319.9pp	-653.5%+266.7pp	-920.3%
Return on Equity	-197.8%-86.6pp	-111.3%+115.5pp	-226.7%-119.8pp	-106.9%+187.8pp	-294.7%+13.3pp	-308.0%
Return on Assets	-78.0%-40.4pp	-37.7%+43.5pp	-81.2%-20.8pp	-60.4%+28.4pp	-88.8%+33.6pp	-122.3%
Current Ratio	0.11-0.1	0.23+0.1	0.13-0.5	0.66+0.4	0.30-0.2	0.50
Debt-to-Equity	1.54-0.4	1.95+0.2	1.79+1.0	0.77-0.2	0.97-0.5	1.52
FCF Margin	N/A	N/A	-482.9%-286.1pp	-196.8%+165.7pp	-362.5%	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	-21.8%+1087.8pp	-1109.6%-599.2pp	-510.4%+355.4pp	-865.8%-497.9pp	-367.9%+90.9pp	-458.8%
Net Margin	N/A	N/A	-72.6%+3768.2pp	-3840.9%-3131.3pp	-709.6%+1218.0pp	-1927.6%-1441.1pp	-486.5%+163.7pp	-650.2%
Return on Equity	-38.2%	N/A	N/A	N/A	N/A	-38.4%-7.3pp	-31.1%+17.2pp	-48.3%
Return on Assets	-27.6%	N/A	-2.8%+165.7pp	-168.5%-145.1pp	-23.4%-10.4pp	-13.0%-4.4pp	-8.6%+2.3pp	-10.9%
Current Ratio	0.38+0.3	0.11-0.0	0.15+0.1	0.06-0.1	0.19-0.0	0.23+0.1	0.11+0.0	0.08
Debt-to-Equity	0.39-1.1	1.54+4.6	-3.03-0.9	-2.12+1.6	-3.73-5.7	1.95-0.7	2.62-0.8	3.42
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Note: The current ratio is below 1.0 (0.11), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

La Rosa Holdings Corp LRHC

$1.7M

Wetouch Technology Inc WETH

$16.0M

New Concep GBR

$3.6M

CHG

$34.5M

Fangdd Network Group Ltd. DUO

$24.3M

Frequently Asked Questions

Is Avalon Globocare Corp profitable?

No, Avalon Globocare Corp (ALBT) reported a net income of -$18.3M in fiscal year 2025.

What is Avalon Globocare Corp's EBITDA?

Avalon Globocare Corp (ALBT) had EBITDA of -$5.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Avalon Globocare Corp's return on equity (ROE)?

Avalon Globocare Corp (ALBT) has a return on equity of -197.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Avalon Globocare Corp's operating cash flow?

Avalon Globocare Corp (ALBT) generated -$4.6M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Avalon Globocare Corp's total assets?

Avalon Globocare Corp (ALBT) had $23.4M in total assets as of fiscal year 2025, including both current and long-term assets.

How many shares does Avalon Globocare Corp have outstanding?

Avalon Globocare Corp (ALBT) had 5M shares outstanding as of fiscal year 2025.

What is Avalon Globocare Corp's current ratio?

Avalon Globocare Corp (ALBT) had a current ratio of 0.11 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is Avalon Globocare Corp's debt-to-equity ratio?

Avalon Globocare Corp (ALBT) had a debt-to-equity ratio of 1.54 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Avalon Globocare Corp's return on assets (ROA)?

Avalon Globocare Corp (ALBT) had a return on assets of -78.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Avalon Globocare Corp's cash runway?

Based on fiscal year 2025 data, Avalon Globocare Corp (ALBT) had $109K in cash against an annual operating cash burn of $4.6M. This gives an estimated cash runway of approximately 0 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

What is Avalon Globocare Corp's Piotroski F-Score?

Avalon Globocare Corp (ALBT) has a Piotroski F-Score of 1 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Avalon Globocare Corp's earnings high quality?

Avalon Globocare Corp (ALBT) has an earnings quality ratio of 0.25x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Avalon Globocare Corp cover its interest payments?

Avalon Globocare Corp (ALBT) has an interest coverage ratio of -5.2x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.